Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Critical review of acylation-stimulating protein physiology in humans and rodents.

Cianflone K, Xia Z, Chen LY.

Biochim Biophys Acta. 2003 Jan 31;1609(2):127-43. Review.

2.
3.
4.

The acylation stimulating protein-adipsin system.

Cianflone K, Maslowska M, Sniderman A.

Int J Obes Relat Metab Disord. 1995 May;19 Suppl 1:S34-8. Review.

PMID:
7550536
5.

Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men.

Koistinen HA, Vidal H, Karonen SL, Dusserre E, Vallier P, Koivisto VA, Ebeling P.

Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):1034-9.

6.

Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice.

Paglialunga S, Fisette A, Yan Y, Deshaies Y, Brouillette JF, Pekna M, Cianflone K.

Am J Physiol Endocrinol Metab. 2008 Mar;294(3):E521-9. Epub 2007 Dec 26.

7.

Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance.

Murray I, Sniderman AD, Cianflone K.

J Lipid Res. 1999 Sep;40(9):1671-6.

8.

Acylation stimulating protein (ASP), an adipocyte autocrine: new directions.

Cianflone K, Maslowska M, Sniderman AD.

Semin Cell Dev Biol. 1999 Feb;10(1):31-41. Review.

PMID:
10355026
9.

Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice.

Murray I, Sniderman AD, Havel PJ, Cianflone K.

J Biol Chem. 1999 Dec 17;274(51):36219-25.

10.

Differential regulation of fatty acid trapping in mouse adipose tissue and muscle by ASP.

Faraj M, Cianflone K.

Am J Physiol Endocrinol Metab. 2004 Jul;287(1):E150-9.

11.

The acylation stimulating protein pathway: clinical implications.

Cianflone K.

Clin Biochem. 1997 Jun;30(4):301-12. Review.

PMID:
9209788
12.

Acylation-stimulating protein precursor proteins in adipose tissue in human obesity.

Xia Z, Cianflone K.

Metabolism. 2003 Oct;52(10):1360-6.

PMID:
14564690
13.

Acylation-stimulating protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice.

Xia Z, Sniderman AD, Cianflone K.

J Biol Chem. 2002 Nov 29;277(48):45874-9. Epub 2002 Sep 19.

14.

A critical evaluation of the putative role of C3adesArg (ASP) in lipid metabolism and hyperapobetalipoproteinemia.

Kildsgaard J, Zsigmond E, Chan L, Wetsel RA.

Mol Immunol. 1999 Sep-Oct;36(13-14):869-76. Review.

PMID:
10698341
16.

The adipsin-ASP pathway and regulation of adipocyte function.

Sniderman AD, Cianflone K.

Ann Med. 1994 Dec;26(6):388-93. Review.

PMID:
7695862
17.

Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein in C57BL/6 mice.

Murray I, Sniderman AD, Cianflone K.

Am J Physiol. 1999 Sep;277(3 Pt 1):E474-80.

18.

Addition of glucose to an oral fat load reduces postprandial free fatty acids and prevents the postprandial increase in complement component 3.

van Oostrom AJ, van Dijk H, Verseyden C, Sniderman AD, Cianflone K, Rabelink TJ, Castro Cabezas M.

Am J Clin Nutr. 2004 Mar;79(3):510-5.

19.

Acylation stimulating protein and triacylglycerol synthesis: potential drug targets?

Cianflone K.

Curr Pharm Des. 2003;9(17):1397-410. Review.

PMID:
12769731
20.

Acylation-stimulating protein (ASP)/complement C3adesArg deficiency results in increased energy expenditure in mice.

Xia Z, Stanhope KL, Digitale E, Simion OM, Chen L, Havel P, Cianflone K.

J Biol Chem. 2004 Feb 6;279(6):4051-7. Epub 2003 Nov 13.

Supplemental Content

Support Center